发明授权
US08106099B2 Combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias
有权
苯卡巴胺与IKr通道阻滞剂的组合及其用于治疗房性心律失常的用途
- 专利标题： Combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias
- 专利标题（中）： 苯卡巴胺与IKr通道阻滞剂的组合及其用于治疗房性心律失常的用途
-
申请号： US10796894申请日： 2004-03-09
-
公开(公告)号： US08106099B2公开(公告)日： 2012-01-31
- 发明人: Joachim Brendel , Klaus Wirth , Heinz Goegelein , Maurits Allessie , Yuri Blaauw
- 申请人： Joachim Brendel , Klaus Wirth , Heinz Goegelein , Maurits Allessie , Yuri Blaauw
- 申请人地址： DE Frankfurt Am Main
- 专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人地址： DE Frankfurt Am Main
- 代理机构： Scully, Scott, Murphy & Presser, P.C.
- 代理商 Serena Farquharson-Torres
- 优先权： DE10312061 20030318
- 主分类号： A01N33/18
- IPC分类号： A01N33/18 ; A01N33/24 ; A61K31/04
摘要：
The invention relates to the combination of one or more IKr channel blockers and of one or more Kv1.5 blockers, in particular phenyl-carboxamides of the formula Ia or Ib or pharmaceutically tolerable salts thereof, and the use of the combination for the treatment of atrial arrhythmias.
公开/授权文献
信息查询
